Showing results (2451-2460 of 6,717) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|January 15, 2019
The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practiceSang Eun Yoon, Su Jin Lee, Jeeyun Lee, et al.Oncotargets and Therapy|January 16, 2019
Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapySamah Nassereddine, Coen J Lap, Imad A TabbaraOncotargets and Therapy|January 16, 2019
Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinomaYu Wang, Weixin Yu, Mingqing He, et al.Oncotargets and Therapy|January 16, 2019
The progression of HMGB1-induced autophagy in cancer biologyTianwei Xu, Lihua Jiang, Zhaoxia WangOncotargets and Therapy|January 19, 2019
Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5pJunfeng Ye, Ruoyan Zhang, Xiaohong Du, et al.Oncotargets and Therapy|January 22, 2019
miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFAJiang Cao, Li Li, Xiao Han, et al.Oncotargets and Therapy|December 7, 2018
Potential clinical application of lncRNAs in non-small cell lung cancerTong Lu, Yuanyong Wang, Di Chen, et al.Oncotargets and Therapy|December 7, 2018
Association of MLH1 single nucleotide polymorphisms with clinical outcomes of first-line irinotecan-based chemotherapy in colorectal cancerDeqiang Wang, Xiaomei Zhang, Yan Zhang, et al.Oncotargets and Therapy|March 15, 2018
Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancerDonggen Jiang, Chutian Xiao, Tuzeng Xian, et al.Oncotargets and Therapy|March 15, 2018
Comparison between multi-slice spiral CT and magnetic resonance imaging in the diagnosis of peritoneal metastasis in primary ovarian carcinomaHong-Lei Guo, Ling He, Yan-Cui Zhu, et al.Pageof 672